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ABSTRACT
Background: The Colorectal Cancer Control Program (CRCCP) of the Centers for Disease Control and
Prevention (CDC) funded 30 grantees to partner with health systems with the goal of increasing screening
for colorectal cancer (CRC).
Methods: Evaluators applied CDC’s Framework for Program Evaluation to design a national level
outcome evaluation for measuring changes in CRC screening rates in partner health systems.
Results: The resulting evaluation design involves the collection and reporting of clinic-level CRC
screening rates supplemented by various tools to support the reporting of high quality, reliable data.
Conclusions: The CRCCP evaluation represents a strong design to measure the primary outcome of
interest, CRC screening rates, and public health practitioners can benefit from lessons learned about
stakeholder involvement, data quality, and the role of evaluators in data dissemination.
Key words: colorectal cancer screening, evaluation, outcome
Statement of Student-Mentored Research: The lead author of this report, Anamika Satsangi, a recent
Master of Public Health graduate, participates in the Oak Ridge Institute for Science and Education
fellowship program at the CDC. Dr. Amy DeGroff, the senior author, serves as her mentor.
https://doi.org/10.21633/jgpha.6.2s16

Colorectal Cancer Control Program (CRCCP) in
2015 for five years (CDC, 2016). Thirty grantees
partnered with healthcare systems to implement
evidence-based interventions (EBIs) such as
provider and client reminders recommended in
the Community Guide (Community Preventive
Services Task Force, 2016) (Figure 1). This
report describes an outcome evaluation designed
to assess changes in screening rates in partner
health systems.

INTRODUCTION
Colorectal cancer (CRC) is a leading cause of
cancer-related death in the U.S. (U.S. Cancer
Statistics Working Group, 2016). Although
screening reduces CRC incidence and mortality
(Whitlock, Lin, Liles, Beil, & Fu, 2008),
screening rates remain low (CDC, 2014). To
increase screening rates, the Centers for Disease
Control and Prevention (CDC) funded the
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Figure 1, Map of CRCCP grantees

framework includes (1) engaging stakeholders,
(2) describing the program, (3) focusing the
evaluation design, (4) gathering credible
evidence, (5) justifying conclusions, and (6)
ensuring use and sharing lessons learned.

METHODS
CDC evaluators applied the Framework for
Program Evaluation to design a national-level
CRCCP evaluation (Figure 1) (CDC, 1999). The

Figure 2: CDC Framework for Program Evaluation

Stakeholders,
including
CDC
program
consultants, leaders, CRCCP grantees, and
healthcare experts, helped to define the purpose
of the evaluation (i.e., program improvement,
accountability)
and
provided
guidance
throughout the evaluation planning process.
Evaluators created a program logic model
(Appendix) describing CRCCP activities and
outcomes that helped focus the design. Using the
logic model, process and outcome evaluation
questions were drafted and vetted with
stakeholders. The primary outcome evaluation
question was, “Do CRC screening rates increase
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in CRCCP partner health systems?” To examine
this question, evaluators determined that
screening rates would be assessed annually over
the five-year program period. In consultation
with stakeholders, evaluators learned that many
grantees planned to work with subsets of primary
care clinics within given health systems rather
than all clinics in a given system. Therefore,
clinic-level screening rate data (vs. health
system-level) were needed.
Evaluators developed a data dictionary detailing
the variables to be reported to CDC by grantees
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along with data collection tools and guidance
documents. Variable selection was informed by
the evaluation purpose and questions. With five
grantees, materials were pilot-tested to assess
clarity, feasibility, and, for tools, functionality.
Based on pilot testing, needed changes were
incorporated. Evaluators also solicited advice
from several national healthcare experts.
Strategies to strengthen data quality were
incorporated into the evaluation design. Finally,
evaluators developed an analysis plan and
selected dissemination strategies to ensure
feedback of evaluation results.

technical assistance, and maintained a document
of frequently asked questions.
Baseline data for clinics recruited in program
year 1 were analyzed by CDC, and reports were
developed for stakeholders. Future dissemination
efforts will use data visualization software that
allows grantees to examine their own data.
DISCUSSION/CONCLUSIONS
Representing the integration of public health and
primary care, the CRCCP offers an opportunity
to increase CRC screening. Using CDC’s
Framework for Evaluation, a strong evaluation
has been designed to assess the CRCCP’s
primary outcome of interest, CRC screening
rates, using medical record data.

RESULTS
Grantees reported baseline clinic-level data,
including screening rates, for all clinics
participating in the CRCCP. Given the
longitudinal evaluation design, grantees also
reported screening rates annually for each clinic
through the end of the cooperative agreement.
The data dictionary was comprised of 110
variables, including health system and clinic
identification codes used to link records over
time. Other variables captured descriptive data
(e.g., health system name, clinic name, number
of patients) and longitudinal data (e.g., screening
rate, EBI implementation).

Several lessons can be derived from this
experience. First, conducting high quality,
systematic outcome evaluations of Federal
programs such as the CRCCP is difficult when
many grantees and potentially hundreds of
implementation sites are involved. Such
scenarios inherently involve data access and
quality
challenges
(DeGroff,
Schooley,
Chapel, & Poister, 2010). However, broad
stakeholder involvement ensured that CDC
crafted a meaningful outcome evaluation
question, identified a feasible data collection
strategy that was not overly burdensome, and
selected data variables accessible to all
participating health system clinics. Second, CDC
evaluators integrated various strategies to ensure
data quality and strengthen reliability, including
developing a data dictionary with standardized
variable definitions, developing guidance on how
to measure screening rates, providing data
collection forms and a web-based reporting
system with built-in validation features, and
delivering various types of technical support.
Finally, evaluators have a critical role to play in
data use such as facilitating interpretation. For
the CRCCP, data feedback mechanisms are in
place, with more sophisticated dissemination
efforts being planned using data visualization
software. Timely dissemination of data to
grantees in a digestible fashion enables
meaningful data feedback and use, and reinforces
the importance of grantees reporting high-quality
data.

Grantees calculated screening rates by medical
chart review and/or electronic health record data.
CDC evaluators developed a guidance document
for grantees to support the consistent and
accurate measurement of screening rates (CDC,
2016). For each clinic, grantees defined the 12month measurement period (e.g., calendar year)
and chose one of four screening rate measures
recommended by CDC (e.g., National
Committee for Quality Assurance, Health
Resources and Services Administration). The
guidance document also offered strategies to
validate the screening rate.
Excel-based data collection forms were created,
and grantees used them to gather baseline and
annual data (Appendix 2). To improve data
quality, these forms incorporated validation
features (e.g., specified ranges, drop-down
boxes). To report clinic data, grantees used a
web-based data reporting system, Clinic Baseline
and Annual Reporting System (CBARS), which
incorporates similar data field edit checks to
strengthen data quality. To support grantees in
their data collection and reporting, evaluators
conducted webinars, provided individual
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Evaluation of public health programs is essential
to ensure accountability to stakeholders,
including funders, and to improve programs.
Good evaluation planning is foundational to
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realizing these aims. Public health practitioners
and evaluators can apply CDC’s Framework for
Program Evaluation and the lessons identified
here to support their own evaluation planning.
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Appendix 1
CRCCP Logic Model
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Appendix 2
Screening Rate and Monitoring and Quality Improvement Sections of
CRCCP Annual Clinic Data Collection Form
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